Monday, September 23, 2024
HomeNews

News

20n Bio Appoints LIANG Shide PhD, as Vice President of Computational Biology

20n Bio, an AI-powered drug discovery startup focusing on designing new proteins for therapeutics, announced the appointment of LIANG Shide, PhD, as Vice President...

Sen-Jam Pharmaceutical Opens Enrollment for Patients in Their COVID Therapy Phase 2 Clinical Trial in Nepal

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy, this week began...

Aravax Appoints Dr Brett Haumann to Board of Directors

Aravax, a clinical stage biotechnology company focused on developing the most advanced novel therapy for peanut allergy, which is designed to be safe, effective,...

Gut Microbiome as a Tool in Regenerative Medicine; Novel Approach Driven by GN Corp Japan With Potentials in Neurological Illnesses

However, there exists another tool involving the gut microbiome (GM) which plays a significant role in supporting all RM tools both directly and indirectly...

Cytovia Therapeutics to Present at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer

Cytovia Therapeutics, LLC ("Cytovia Therapeutics"), a global biotechnology company focused on harnessing the power of natural killer (NK) cells to fight cancer through multispecific...
0FansLike
0FollowersFollow
spot_img

Hot Topics